Xlife Sciences AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CHF 1.03 million compared to CHF 0.806066 million a year ago. Net income was CHF 14.31 million compared to CHF 53.42 million a year ago.

Basic earnings per share from continuing operations was CHF 2.72 compared to CHF 11.3 a year ago. Diluted earnings per share from continuing operations was CHF 2 compared to CHF 8.66 a year ago.